Skip to content

AnuBio

Plug and Play · Reprogramming immunomodulation using AI to cure cancer

Competitors

Companies closest to AnuBio
CompanyProgram
Parallel BioShared: immune system, drug discovery, cureActiveAIYCS21

Adjacent

Also from Plug and Play in AI

All of Plug and Play

Programs

Programs AnuBio went through
ProgramCohortSource
Plug and PlayNot statedPlug and Play Page

About AnuBio

"AnuBio is a pioneering company in the fields of Artificial Intelligence, Deeptech, and Health, dedicated to reprogramming immunomodulation for cancer treatment. Utilizing phenotypic drug discovery of combinatorial biologics, AnuBio has developed a pair of groundbreaking technologies that enhance the discovery of novel immunomodulators by 100-fold. These technologies include PHENOMS, a proprietary in vitro phenotypic screening platform combined with multispecific biologics, and TRAILBLAZER AI, a revolutionary architecture AI model of the immune system. By synergizing these technologies, AnuBio has created a closed-loop lab-AI research platform that integrates real-world data and validation from PHENOMS with predictive insights from TRAILBLAZER AI. This innovative approach streamlines the drug discovery process, offering valuable predictions for success at every stage."

Category
AI
Location
United States
Checked
3h ago

AnuBio: questions

Which accelerators did AnuBio go through?

AnuBio is listed by Plug and Play.

Where is AnuBio based?

AnuBio lists United States as its location on Plug and Play's page.

Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.

New startups by email

Mondays: new YC data, AI and devtools companies and status changes, only when something changed.

Double opt-in. Unsubscribe any time.